Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-10-25
2008-12-30
Desai, Rita J (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S114000
Reexamination Certificate
active
07470707
ABSTRACT:
A crystalline clopidogrel naphthalenesulfonate or a hydrate thereof, a method for preparing same, and a pharmaceutical composition containing same are provided.
REFERENCES:
patent: 4847265 (1989-07-01), Badore et al.
patent: 6429210 (2002-08-01), Bousquet et al.
patent: 2005/0256152 (2005-11-01), Doser et al.
patent: 0 281 459 (1988-09-01), None
Caplus English abstract JP 04128265 , DN 117:212338, Izawa Toshio et al Apr. 1992.
PharmaceuticalSalts . . . Berge Stephen et al. 1977.
Kim Cheol Kyung
Kim Eun Sook
Kim Han Kyong
Kim Hee Seock
Kwon Bo Sung
Desai Rita J
Hanmi Pharm. Co., Ltd
Sughrue & Mion, PLLC
LandOfFree
Crystalline monohydrate clopidogrel naphthalenedisulfonate... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline monohydrate clopidogrel naphthalenedisulfonate..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline monohydrate clopidogrel naphthalenedisulfonate... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4027665